83 related articles for article (PubMed ID: 12692260)
21. Elevated expression of MITF counteracts B-RAF-stimulated melanocyte and melanoma cell proliferation.
Wellbrock C; Marais R
J Cell Biol; 2005 Aug; 170(5):703-8. PubMed ID: 16129781
[TBL] [Abstract][Full Text] [Related]
22. Visible light modulates the expression of cancer-retina antigens.
Bazhin AV; Schadendorf D; Owen RW; Zernii EY; Philippov PP; Eichmüller SB
Mol Cancer Res; 2008 Jan; 6(1):110-8. PubMed ID: 18184973
[TBL] [Abstract][Full Text] [Related]
23. MEK/ERK and signal transducer and activator of transcription signaling pathways modulate oncostatin M-stimulated CCL2 expression in human osteoblasts through a common transcription factor.
Lin SK; Kok SH; Yeh FT; Kuo MY; Lin CC; Wang CC; Goldring SR; Hong CY
Arthritis Rheum; 2004 Mar; 50(3):785-93. PubMed ID: 15022320
[TBL] [Abstract][Full Text] [Related]
24. Expression of oncostatin M and its receptors in normal and cirrhotic human liver.
Znoyko I; Sohara N; Spicer SS; Trojanowska M; Reuben A
J Hepatol; 2005 Nov; 43(5):893-900. PubMed ID: 16169119
[TBL] [Abstract][Full Text] [Related]
25. [An immunocytochemical investigation of antigen expression by skin melanoma cells cultured for vaccine production].
Moiseenko VM; Danilova AB; Danilov AO; Turkevich EA; Baldueva IA; Matsko DE
Vopr Onkol; 2008; 54(3):303-14. PubMed ID: 18652234
[TBL] [Abstract][Full Text] [Related]
26. Oncostatin M, a multifunctional cytokine.
Tanaka M; Miyajima A
Rev Physiol Biochem Pharmacol; 2003; 149():39-52. PubMed ID: 12811586
[TBL] [Abstract][Full Text] [Related]
27. TNF-alpha regulates mouse fetal hepatic maturation induced by oncostatin M and extracellular matrices.
Kamiya A; Gonzalez FJ
Hepatology; 2004 Sep; 40(3):527-36. PubMed ID: 15349890
[TBL] [Abstract][Full Text] [Related]
28. Oncostatin M: a pleiotropic cytokine in the central nervous system.
Chen SH; Benveniste EN
Cytokine Growth Factor Rev; 2004 Oct; 15(5):379-91. PubMed ID: 15450253
[TBL] [Abstract][Full Text] [Related]
29. Co-expression of SOX9 and SOX10 during melanocytic differentiation in vitro.
Cook AL; Smith AG; Smit DJ; Leonard JH; Sturm RA
Exp Cell Res; 2005 Aug; 308(1):222-35. PubMed ID: 15896776
[TBL] [Abstract][Full Text] [Related]
30. Defective activations of STAT3 Ser727 and PKC isoforms lead to oncostatin M resistance in metastatic melanoma cells.
Lacreusette A; Barbieux I; Nguyen JM; Pandolfino MC; Dréno B; Jacques Y; Godard A; Blanchard F
J Pathol; 2009 Apr; 217(5):665-76. PubMed ID: 19097071
[TBL] [Abstract][Full Text] [Related]
31. Melanoma-associated antigen tyrosinase but not Melan-A/MART-1 expression and presentation dissociate during the heat shock response.
Milani V; Frankenberger B; Heinz O; Brandl A; Ruhland S; Issels RD; Noessner E
Int Immunol; 2005 Mar; 17(3):257-68. PubMed ID: 15642953
[TBL] [Abstract][Full Text] [Related]
32. Divergent effects of oncostatin M on astroglioma cells: influence on cell proliferation, invasion, and expression of matrix metalloproteinases.
Chen SH; Gillespie GY; Benveniste EN
Glia; 2006 Jan; 53(2):191-200. PubMed ID: 16206166
[TBL] [Abstract][Full Text] [Related]
33. Cancer/testis antigen expression in human mesenchymal stem cells: down-regulation of SSX impairs cell migration and matrix metalloproteinase 2 expression.
Cronwright G; Le Blanc K; Götherström C; Darcy P; Ehnman M; Brodin B
Cancer Res; 2005 Mar; 65(6):2207-15. PubMed ID: 15781633
[TBL] [Abstract][Full Text] [Related]
34. Qualitative difference between the cytotoxic T lymphocyte responses to melanocyte antigens in melanoma and vitiligo.
Palermo B; Garbelli S; Mantovani S; Scoccia E; Da Prada GA; Bernabei P; Avanzini MA; Brazzelli V; Borroni G; Giachino C
Eur J Immunol; 2005 Nov; 35(11):3153-62. PubMed ID: 16224813
[TBL] [Abstract][Full Text] [Related]
35. The antigen processing machinery of class I human leukocyte antigens: linked patterns of gene expression in neoplastic cells.
Giorda E; Sibilio L; Martayan A; Moretti S; Venturo I; Mottolese M; Ferrara GB; Cappellacci S; Eibenschutz L; Catricalà C; Grammatico P; Giacomini P
Cancer Res; 2003 Jul; 63(14):4119-27. PubMed ID: 12874016
[TBL] [Abstract][Full Text] [Related]
36. Immunohistochemical analysis of the IL-6 family of cytokines and their receptors in benign, hyperplasic, and malignant human prostate.
Royuela M; Ricote M; Parsons MS; García-Tuñón I; Paniagua R; de Miguel MP
J Pathol; 2004 Jan; 202(1):41-9. PubMed ID: 14694520
[TBL] [Abstract][Full Text] [Related]
37. Relationship between responsiveness of cancer cells to Oncostatin M and/or IL-6 and survival of stage III melanoma patients treated with tumour-infiltrating lymphocytes.
Lacreusette A; Lartigue A; Nguyen JM; Barbieux I; Pandolfino MC; Paris F; Khammari A; Dréno B; Jacques Y; Blanchard F; Godard A
J Pathol; 2008 Dec; 216(4):451-9. PubMed ID: 18798220
[TBL] [Abstract][Full Text] [Related]
38. Brn-2 represses microphthalmia-associated transcription factor expression and marks a distinct subpopulation of microphthalmia-associated transcription factor-negative melanoma cells.
Goodall J; Carreira S; Denat L; Kobi D; Davidson I; Nuciforo P; Sturm RA; Larue L; Goding CR
Cancer Res; 2008 Oct; 68(19):7788-94. PubMed ID: 18829533
[TBL] [Abstract][Full Text] [Related]
39. Epigenetic silencing of the CIITA gene and posttranscriptional regulation of class II MHC genes in ocular melanoma cells.
Radosevich M; Song Z; Gorga JC; Ksander B; Ono SJ
Invest Ophthalmol Vis Sci; 2004 Sep; 45(9):3185-95. PubMed ID: 15326139
[TBL] [Abstract][Full Text] [Related]
40. Aberrant expression of novel and previously described cell membrane markers in human breast cancer cell lines and tumors.
Huang H; Groth J; Sossey-Alaoui K; Hawthorn L; Beall S; Geradts J
Clin Cancer Res; 2005 Jun; 11(12):4357-64. PubMed ID: 15958618
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
